Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03368157 · ClinicalTrials.gov registry record

PREG-MS: New England MS Pregnancy Registry

A clinical trial, sponsored by Brigham and Women's Hospital.

Completed
Registry status
168
Enrollment target

NCT03368157: Completed study, sponsored by Brigham and Women's Hospital.

NCT03368157 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 168 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03368157 has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
168 participants
Enrollment target

Study Summary

The purpose of the study is to develop a detailed pregnancy registry of patients with Multiple Sclerosis in the New England states. Women with a diagnosis of MS that are either pregnant or actively planning to become pregnant are eligible to participate. The study will solely take place through phone interviews. One of the study coordinator at the Partners MS Center will contact the participant for an intake phone interview where general information about the individual, their pregnancy and their MS will be collected. Thereafter the coordinator will contact the participant every 3 months for 20 minutes follow up interviews. After birth, the coordinator will collect information on the growth and development of the participant's baby. Pediatric interviews will be conducted at 2, 4, 6, 9, 12, 18, 24, 36 months. Information from the participant's neurologist and obstetrician, as well as information from the baby's pediatrician, will be made available to the study staff at regular intervals throughout the duration of the study. Through this study, the investigators hope to learn more about the effects of MS on pregnancy and pediatric development, and about the effects of pregnancy on the course of MS.

Primary Outcome

The investigators assessed the correlation between EDSS scores and the presence of pregnancy complications, or the lack thereof.

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2017-04-07
Est. Completion 2022-12-07
Brigham and Women's Hospital

937 total trials

What the finished NCT03368157 record still lists

NCT03368157 is an observational study that tracks outcomes without assigning an intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT03368157 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03368157 about?

NCT03368157 is a clinical study titled "PREG-MS: New England MS Pregnancy Registry". The purpose of the study is to develop a detailed pregnancy registry of patients with Multiple Sclerosis in the New England states. Women with a diagnosis of MS that are either pregnant or actively planning to become pregnant are eligible to participate. The study will solely take place through pho...

What is the current status of trial NCT03368157?

This trial is currently completed. The enrollment target is 168 participants. The study started on 2017-04-07. Estimated completion is 2022-12-07.

Who is sponsoring clinical trial NCT03368157?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02118922 · 168 participants

    A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

  • NCT03536897 · 168 participants

    IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry

  • NCT04078230 · 168 participants · NA

    Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

  • NCT04159168 · 168 participants · NA

    Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03368157, the US trial registry maintained by the National Library of Medicine. NCT03368157 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.